Establishment Labs Holdings (ESTA) Current Deferred Revenue (2023 - 2024)
Establishment Labs Holdings (ESTA) posted quarterly Current Deferred Revenue of $1.7 million for Q3 2024, little changed quarter-over-quarter from $1.7 million in Q2 2024.
Establishment Labs Holdings (ESTA) Current Deferred Revenue (2023 - 2024) Analysis & Trends
Establishment Labs Holdings' Current Deferred Revenue history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2024.
- In Q3 2024, Current Deferred Revenue changed N/A year-over-year to $1.7 million; the TTM figure through Sep 2024 stood at $1.7 million (changed N/A YoY), while the FY2023 annual figure was $1.8 million, changed N/A from the prior year.
- Current Deferred Revenue for Q3 2024 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.8 million in Q4 2023, with the low at $1.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.84 Mn |